Partners

Corning 2024 Partner

Corning
Expertise Partner

Corning is a global, leading manufacturer of lab tools for growing cells, bioprocess manufacturing, liquid handling, benchtop equipment, among other solutions for life sciences. Corning strives to improve efficiencies and develop innovations that enable researchers to create breakthrough discoveries in areas like cancer, primary cells, stem cells, drug discovery, cell and gene therapy and lab automation. Learn more about Corning's novel 3D cell culture tools for oncology assays and high throughput screening by visiting:

www.corning.com

bennubio 2024 Partner

BennuBio
Innovation Partner

Flow cytometry is the most powerful tool for the analysis of cellular populations, but there is still a wealth of untapped potential for additional applications. BennuBio Inc. has greatly expanded the power of flow cytometry by developing instruments that can use the flow cytometry paradigm to analyze samples regardless of particle size or sample volume. Moreover, these instruments simplify workflows to save time and money. Our gentle approach retains sample viability and morphology while analyzing at considerably faster rates. Thereby, improving
diagnostics, decreasing time to markets, and accelerating fundamental health science research.

www.bennubio.com

Mimetas

MIMETAS
Innovation Partner

MIMETAS is a global leader in disease modeling using Organ-on-a-Chip technologies. Founded in 2013 in the Netherlands, MIMETAS strives to contribute to ground-breaking therapies with their screenable, physiologically relevant human disease models. By combining technological strengths and expertise, MIMETAS establishes strong drug development partnerships with and offers services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases.

www.mimetas.com

molecular devices

Molecular Devices
Exhibition Partner

Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software, and consumables for life science research and pharmaceutical and biotherapeutic development. We believe in the revolutionary promise of 3D cell models to advance next-generation drug discovery and support these advanced research methods with a robust portfolio that includes end-to-end automated cell culture systems, assay-ready organoid expansion services, high-content, high-throughput imaging systems, and user-friendly AI-powered data analysis. Molecular Devices is committed to the continual development of innovative solutions that enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics.

www.moleculardevices.com